PSYCHIATRY EDUCATION FORUM ACADEMY’S MANAGING CLOZAPINE ADVERSE EVENTS UNDERSTANDING THE BASICS & BEYOND Introduction: Clozapine was FDA-approved for treatment-refractory schizophrenia in 1989 and has remained the gold standard treatment since then for this indication. Clozapine has established efficacy…
Clozapine, a cornerstone in the treatment of treatment-resistant schizophrenia, is known for its efficacy in patients who have not responded to other antipsychotic medications. However, its use comes with the need for meticulous monitoring due to its narrow…
Clinical Case Discussion: QTc Prolongation Risk with Psychotropics Dr. Satinderpal Kaur (Family Medicine) & Dr. Harvinder Singh (Psychiatry) will continue their discussion to integrate clinical cases from Psychiatry and Medicine. Our 6th clinical case discussion will focus on:1. Understanding…
Alzheimer’s disease, a progressive neurodegenerative disorder, not only affects memory and cognitive functions but also takes a toll on emotions and motivation. Among the many behavioral changes associated with Alzheimer’s, apathy is one of the most common and…
Let’s Do It Together
Subscribe To The Blog
Report
There was a problem reporting this post.
Block Member?
Please confirm you want to block this member.
You will no longer be able to:
See blocked member's posts
Mention this member in posts
Invite this member to groups
Message this member
Add this member as a connection
Please note:
This action will also remove this member from your connections and send a report to the site admin.
Please allow a few minutes for this process to complete.
PSYCHIATRY EDUCATION FORUM ACADEMY’S MANAGING CLOZAPINE ADVERSE EVENTS UNDERSTANDING THE BASICS & BEYOND Introduction: Clozapine was FDA-approved for treatment-refractory schizophrenia in 1989 and has remained the gold standard treatment since then for this indication. Clozapine has established efficacy…
